Introduction: It has been observed that there are gender differences in the progression of CKD patients to ESRD. In addition, the prevalence of CKD is higher in women. In view of the progressive increase in the prevalence of CKD, it is apt to understand the factors that drive these gender differences. This study is an attempt to evaluate the distribution of risk factors of CKD across different genders in adults living in a rural Nigerian community Methods: We conducted a cross-sectional survey of adult inhabitants of Ndimgbu, Nnewi, a typical rural settlement in South Eastern Nigeria; this was done during a health outreach program. Consenting adults were recruited using convenience sampling technique An interviewer administered questionnaire, designed for this study, was used to obtain data on sociodemographic characteristics and risk factors for CKD such as history of hypertension, DM, cardiovascular disease (CVD), or AKI; use of heavy metal containing cosmetics, tobacco, analgesics, excess alcohol. Other data included family history of hypertension, DM, and CVD. Tests involving blood and urine were not carried out at this stage. Blood pressure was measured in the standard way Data collected was double entered in Microsoft Excel spreadsheet and analyzed using EPI INFO ver 7.2.2.16. Fisher's exact test were used to examine categorical variables while continuous variables were analyzed using the t test Results: The results of 63 adults with complete data were analyzed. Mean age was 51.3AE16.0 and 42 (66.7%) were females. 31 (50.0%) of the participants were farmers. There was a statistically significant difference with tobacco use and alcohol intake. (Table 1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.